APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Drugs Packaging

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Parenteral Drugs Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchParenteral Drugs Packaging Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Drugs Packaging Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Parenteral Drugs Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Drugs Packaging Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Drugs Packaging Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Parenteral Drugs Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Parenteral Drugs Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Parenteral Drugs Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parenteral Drugs Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Parenteral Drugs Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Parenteral Drugs Packaging include Ypsomed Holding AG, Gerresheimer AG, SiO2 Medical Products, Schott AG, Ompi Stevanato Group, Becton Dickinson and Company, MeadWestvaco Corporation, Unilife Corporation Inc and West Pharmaceutical Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Parenteral Drugs Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Parenteral Drugs Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Parenteral Drugs Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parenteral Drugs Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Parenteral Drugs Packaging Segment by Company

Ypsomed Holding AG

Gerresheimer AG

SiO2 Medical Products

Schott AG

Ompi Stevanato Group

Becton Dickinson and Company

MeadWestvaco Corporation

Unilife Corporation Inc

West Pharmaceutical Services

Terumo Corporation

Berry Plastics Corporation

Owens-Illinois

RPC Group

Graphic Packaging Group

Parenteral Drugs Packaging Segment by Type

Polyvinyl Chloride (PVC)

Polyolefin

Parenteral Drugs Packaging Segment by Application

Large Volume Parenteral (LVP)

Small Volume Parenteral (SVP)

Parenteral Drugs Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Parenteral Drugs Packaging market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Parenteral Drugs Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Parenteral Drugs Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Parenteral Drugs Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Parenteral Drugs Packaging Industry Trends Table 2. Parenteral Drugs Packaging Industry Drivers Table 3. Parenteral Drugs Packaging Industry Opportunities and Challenges Table 4. Parenteral Drugs Packaging Industry Restraints Table 5. Global Parenteral Drugs Packaging Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Parenteral Drugs Packaging Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Parenteral Drugs Packaging Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Parenteral Drugs Packaging Sales Market Share by Manufacturers Table 9. Global Parenteral Drugs Packaging Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Parenteral Drugs Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Parenteral Drugs Packaging Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Parenteral Drugs Packaging Manufacturers, Product Type & Application Table 13. Global Parenteral Drugs Packaging Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Parenteral Drugs Packaging by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polyvinyl Chloride (PVC) Table 17. Major Manufacturers of Polyolefin Table 18. Global Parenteral Drugs Packaging Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Parenteral Drugs Packaging Sales by Type (2021-2026) & (k units) Table 20. Global Parenteral Drugs Packaging Sales by Type (2027-2032) & (k units) Table 21. Global Parenteral Drugs Packaging Sales Market Share by Type (2021-2026) Table 22. Global Parenteral Drugs Packaging Sales Market Share by Type (2027-2032) Table 23. Global Parenteral Drugs Packaging Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Parenteral Drugs Packaging Revenue by Type (2021-2026) & (k units) Table 25. Global Parenteral Drugs Packaging Revenue by Type (2027-2032) & (k units) Table 26. Global Parenteral Drugs Packaging Revenue Market Share by Type (2021-2026) Table 27. Global Parenteral Drugs Packaging Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Large Volume Parenteral (LVP) Table 29. Major Manufacturers of Small Volume Parenteral (SVP) Table 30. Global Parenteral Drugs Packaging Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Parenteral Drugs Packaging Sales by Application (2021-2026) & (k units) Table 32. Global Parenteral Drugs Packaging Sales by Application (2027-2032) & (k units) Table 33. Global Parenteral Drugs Packaging Sales Market Share by Application (2021-2026) Table 34. Global Parenteral Drugs Packaging Sales Market Share by Application (2027-2032) Table 35. Global Parenteral Drugs Packaging Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Parenteral Drugs Packaging Revenue by Application (2021-2026) & (k units) Table 37. Global Parenteral Drugs Packaging Revenue by Application (2027-2032) & (k units) Table 38. Global Parenteral Drugs Packaging Revenue Market Share by Application (2021-2026) Table 39. Global Parenteral Drugs Packaging Revenue Market Share by Application (2027-2032) Table 40. Global Parenteral Drugs Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Parenteral Drugs Packaging Sales by Region (2021-2026) & (k units) Table 42. Global Parenteral Drugs Packaging Sales Market Share by Region (2021-2026) Table 43. Global Parenteral Drugs Packaging Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Parenteral Drugs Packaging Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Parenteral Drugs Packaging Sales by Country (2021-2026) & (k units) Table 47. North America Parenteral Drugs Packaging Sales by Country (2027-2032) & (k units) Table 48. Europe Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Parenteral Drugs Packaging Sales by Country (2021-2026) & (k units) Table 50. Europe Parenteral Drugs Packaging Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Parenteral Drugs Packaging Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Parenteral Drugs Packaging Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Parenteral Drugs Packaging Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Parenteral Drugs Packaging Sales by Country (2027-2032) & (k units) Table 57. Global Parenteral Drugs Packaging Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Parenteral Drugs Packaging Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Parenteral Drugs Packaging Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Parenteral Drugs Packaging Revenue Market Share by Region (2021-2026) Table 61. Global Parenteral Drugs Packaging Revenue Market Share by Region (2027-2032) Table 62. Ypsomed Holding AG Company Information Table 63. Ypsomed Holding AG Business Overview Table 64. Ypsomed Holding AG Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Ypsomed Holding AG Parenteral Drugs Packaging Product Portfolio Table 66. Ypsomed Holding AG Recent Development Table 67. Gerresheimer AG Company Information Table 68. Gerresheimer AG Business Overview Table 69. Gerresheimer AG Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Gerresheimer AG Parenteral Drugs Packaging Product Portfolio Table 71. Gerresheimer AG Recent Development Table 72. SiO2 Medical Products Company Information Table 73. SiO2 Medical Products Business Overview Table 74. SiO2 Medical Products Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. SiO2 Medical Products Parenteral Drugs Packaging Product Portfolio Table 76. SiO2 Medical Products Recent Development Table 77. Schott AG Company Information Table 78. Schott AG Business Overview Table 79. Schott AG Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Schott AG Parenteral Drugs Packaging Product Portfolio Table 81. Schott AG Recent Development Table 82. Ompi Stevanato Group Company Information Table 83. Ompi Stevanato Group Business Overview Table 84. Ompi Stevanato Group Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Ompi Stevanato Group Parenteral Drugs Packaging Product Portfolio Table 86. Ompi Stevanato Group Recent Development Table 87. Becton Dickinson and Company Company Information Table 88. Becton Dickinson and Company Business Overview Table 89. Becton Dickinson and Company Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Becton Dickinson and Company Parenteral Drugs Packaging Product Portfolio Table 91. Becton Dickinson and Company Recent Development Table 92. MeadWestvaco Corporation Company Information Table 93. MeadWestvaco Corporation Business Overview Table 94. MeadWestvaco Corporation Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. MeadWestvaco Corporation Parenteral Drugs Packaging Product Portfolio Table 96. MeadWestvaco Corporation Recent Development Table 97. Unilife Corporation Inc Company Information Table 98. Unilife Corporation Inc Business Overview Table 99. Unilife Corporation Inc Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Unilife Corporation Inc Parenteral Drugs Packaging Product Portfolio Table 101. Unilife Corporation Inc Recent Development Table 102. West Pharmaceutical Services Company Information Table 103. West Pharmaceutical Services Business Overview Table 104. West Pharmaceutical Services Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. West Pharmaceutical Services Parenteral Drugs Packaging Product Portfolio Table 106. West Pharmaceutical Services Recent Development Table 107. Terumo Corporation Company Information Table 108. Terumo Corporation Business Overview Table 109. Terumo Corporation Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Terumo Corporation Parenteral Drugs Packaging Product Portfolio Table 111. Terumo Corporation Recent Development Table 112. Berry Plastics Corporation Company Information Table 113. Berry Plastics Corporation Business Overview Table 114. Berry Plastics Corporation Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Berry Plastics Corporation Parenteral Drugs Packaging Product Portfolio Table 116. Berry Plastics Corporation Recent Development Table 117. Owens-Illinois Company Information Table 118. Owens-Illinois Business Overview Table 119. Owens-Illinois Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Owens-Illinois Parenteral Drugs Packaging Product Portfolio Table 121. Owens-Illinois Recent Development Table 122. RPC Group Company Information Table 123. RPC Group Business Overview Table 124. RPC Group Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. RPC Group Parenteral Drugs Packaging Product Portfolio Table 126. RPC Group Recent Development Table 127. Graphic Packaging Group Company Information Table 128. Graphic Packaging Group Business Overview Table 129. Graphic Packaging Group Parenteral Drugs Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Graphic Packaging Group Parenteral Drugs Packaging Product Portfolio Table 131. Graphic Packaging Group Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Parenteral Drugs Packaging Distributors List Table 135. Parenteral Drugs Packaging Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Parenteral Drugs Packaging Product Image Figure 2. Global Parenteral Drugs Packaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Drugs Packaging Market Size (2021-2032) & (US$ Million) Figure 4. Global Parenteral Drugs Packaging Sales (2021-2032) & (k units) Figure 5. Global Parenteral Drugs Packaging Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Parenteral Drugs Packaging Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polyvinyl Chloride (PVC) Image Figure 9. Polyolefin Image Figure 10. Global Parenteral Drugs Packaging Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Parenteral Drugs Packaging Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Parenteral Drugs Packaging Sales Market Share by Type (2021-2032) Figure 13. Global Parenteral Drugs Packaging Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Parenteral Drugs Packaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Parenteral Drugs Packaging Revenue Market Share by Type (2021-2032) Figure 16. Large Volume Parenteral (LVP) Image Figure 17. Small Volume Parenteral (SVP) Image Figure 18. Global Parenteral Drugs Packaging Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Parenteral Drugs Packaging Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Parenteral Drugs Packaging Sales Market Share by Application (2021-2032) Figure 21. Global Parenteral Drugs Packaging Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Parenteral Drugs Packaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Parenteral Drugs Packaging Revenue Market Share by Application (2021-2032) Figure 24. North America Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Parenteral Drugs Packaging Sales Market Share by Country (2021-2032) Figure 26. U.S. Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Parenteral Drugs Packaging Sales Market Share by Country (2021-2032) Figure 31. Germany Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Parenteral Drugs Packaging Sales Market Share by Country (2021-2032) Figure 38. China Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Parenteral Drugs Packaging Sales Market Share by Country (2021-2032) Figure 46. Brazil Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Parenteral Drugs Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Parenteral Drugs Packaging Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Parenteral Drugs Packaging Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Parenteral Drugs Packaging Revenue (2021-2032) & (US$ Million) Figure 57. North America Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Parenteral Drugs Packaging Revenue (2021-2032) & (US$ Million) Figure 59. Europe Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Parenteral Drugs Packaging Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Parenteral Drugs Packaging Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Parenteral Drugs Packaging Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Parenteral Drugs Packaging Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polyvinyl Chloride (PVC)
  • Polyolefin
Applications
  • Large Volume Parenteral (LVP)
  • Small Volume Parenteral (SVP)
Companies covered
  • Ypsomed Holding AG
  • Gerresheimer AG
  • SiO2 Medical Products
  • Schott AG
  • Ompi Stevanato Group
  • Becton Dickinson and Company
  • MeadWestvaco Corporation
  • Unilife Corporation Inc
  • West Pharmaceutical Services
  • Terumo Corporation
  • Berry Plastics Corporation
  • Owens-Illinois
  • RPC Group
  • Graphic Packaging Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Parenteral Drugs Packaging Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Parenteral Drugs Packaging Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Parenteral Drugs Packaging Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Parenteral Drugs Packaging Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Parenteral Drugs Packaging Market Dynamics
  1. 2.1 Parenteral Drugs Packaging Industry Trends
  2. 2.2 Parenteral Drugs Packaging Industry Drivers
  3. 2.3 Parenteral Drugs Packaging Industry Opportunities and Challenges
  4. 2.4 Parenteral Drugs Packaging Industry Restraints
3 Parenteral Drugs Packaging Market by Manufacturers
  1. 3.1 Global Parenteral Drugs Packaging Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Parenteral Drugs Packaging Sales by Manufacturers (2021-2026)
  3. 3.3 Global Parenteral Drugs Packaging Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Parenteral Drugs Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Parenteral Drugs Packaging Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Parenteral Drugs Packaging Manufacturers, Product Type & Application
  7. 3.7 Global Parenteral Drugs Packaging Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Parenteral Drugs Packaging Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Parenteral Drugs Packaging Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Parenteral Drugs Packaging Tier 1, Tier 2, and Tier 3
4 Parenteral Drugs Packaging Market by Type
  1. 4.1 Parenteral Drugs Packaging Type Introduction
  2. 4.1.1 Polyvinyl Chloride (PVC)
  3. 4.1.2 Polyolefin
  4. 4.2 Global Parenteral Drugs Packaging Sales by Type
  5. 4.2.1 Global Parenteral Drugs Packaging Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Parenteral Drugs Packaging Sales by Type (2021-2032)
  7. 4.2.3 Global Parenteral Drugs Packaging Sales Market Share by Type (2021-2032)
  8. 4.3 Global Parenteral Drugs Packaging Revenue by Type
  9. 4.3.1 Global Parenteral Drugs Packaging Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Parenteral Drugs Packaging Revenue by Type (2021-2032)
  11. 4.3.3 Global Parenteral Drugs Packaging Revenue Market Share by Type (2021-2032)
5 Parenteral Drugs Packaging Market by Application
  1. 5.1 Parenteral Drugs Packaging Application Introduction
  2. 5.1.1 Large Volume Parenteral (LVP)
  3. 5.1.2 Small Volume Parenteral (SVP)
  4. 5.2 Global Parenteral Drugs Packaging Sales by Application
  5. 5.2.1 Global Parenteral Drugs Packaging Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Parenteral Drugs Packaging Sales by Application (2021-2032)
  7. 5.2.3 Global Parenteral Drugs Packaging Sales Market Share by Application (2021-2032)
  8. 5.3 Global Parenteral Drugs Packaging Revenue by Application
  9. 5.3.1 Global Parenteral Drugs Packaging Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Parenteral Drugs Packaging Revenue by Application (2021-2032)
  11. 5.3.3 Global Parenteral Drugs Packaging Revenue Market Share by Application (2021-2032)
6 Global Parenteral Drugs Packaging Sales by Region
  1. 6.1 Global Parenteral Drugs Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Parenteral Drugs Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Parenteral Drugs Packaging Sales by Region (2021-2026)
  4. 6.2.2 Global Parenteral Drugs Packaging Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Parenteral Drugs Packaging Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Parenteral Drugs Packaging Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Parenteral Drugs Packaging Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Parenteral Drugs Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Parenteral Drugs Packaging Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Parenteral Drugs Packaging Revenue by Region
  1. 7.1 Global Parenteral Drugs Packaging Revenue by Region
  2. 7.1.1 Global Parenteral Drugs Packaging Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Parenteral Drugs Packaging Revenue by Region (2021-2026)
  4. 7.1.3 Global Parenteral Drugs Packaging Revenue by Region (2027-2032)
  5. 7.1.4 Global Parenteral Drugs Packaging Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Parenteral Drugs Packaging Revenue (2021-2032)
  8. 7.2.2 North America Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Parenteral Drugs Packaging Revenue (2021-2032)
  11. 7.3.2 Europe Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Parenteral Drugs Packaging Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Parenteral Drugs Packaging Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Parenteral Drugs Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ypsomed Holding AG
  2. 8.1.1 Ypsomed Holding AG Company Information
  3. 8.1.2 Ypsomed Holding AG Business Overview
  4. 8.1.3 Ypsomed Holding AG Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ypsomed Holding AG Parenteral Drugs Packaging Product Portfolio
  6. 8.1.5 Ypsomed Holding AG Recent Developments
  7. 8.2 Gerresheimer AG
  8. 8.2.1 Gerresheimer AG Company Information
  9. 8.2.2 Gerresheimer AG Business Overview
  10. 8.2.3 Gerresheimer AG Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Gerresheimer AG Parenteral Drugs Packaging Product Portfolio
  12. 8.2.5 Gerresheimer AG Recent Developments
  13. 8.3 SiO2 Medical Products
  14. 8.3.1 SiO2 Medical Products Company Information
  15. 8.3.2 SiO2 Medical Products Business Overview
  16. 8.3.3 SiO2 Medical Products Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SiO2 Medical Products Parenteral Drugs Packaging Product Portfolio
  18. 8.3.5 SiO2 Medical Products Recent Developments
  19. 8.4 Schott AG
  20. 8.4.1 Schott AG Company Information
  21. 8.4.2 Schott AG Business Overview
  22. 8.4.3 Schott AG Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Schott AG Parenteral Drugs Packaging Product Portfolio
  24. 8.4.5 Schott AG Recent Developments
  25. 8.5 Ompi Stevanato Group
  26. 8.5.1 Ompi Stevanato Group Company Information
  27. 8.5.2 Ompi Stevanato Group Business Overview
  28. 8.5.3 Ompi Stevanato Group Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ompi Stevanato Group Parenteral Drugs Packaging Product Portfolio
  30. 8.5.5 Ompi Stevanato Group Recent Developments
  31. 8.6 Becton Dickinson and Company
  32. 8.6.1 Becton Dickinson and Company Company Information
  33. 8.6.2 Becton Dickinson and Company Business Overview
  34. 8.6.3 Becton Dickinson and Company Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Becton Dickinson and Company Parenteral Drugs Packaging Product Portfolio
  36. 8.6.5 Becton Dickinson and Company Recent Developments
  37. 8.7 MeadWestvaco Corporation
  38. 8.7.1 MeadWestvaco Corporation Company Information
  39. 8.7.2 MeadWestvaco Corporation Business Overview
  40. 8.7.3 MeadWestvaco Corporation Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MeadWestvaco Corporation Parenteral Drugs Packaging Product Portfolio
  42. 8.7.5 MeadWestvaco Corporation Recent Developments
  43. 8.8 Unilife Corporation Inc
  44. 8.8.1 Unilife Corporation Inc Company Information
  45. 8.8.2 Unilife Corporation Inc Business Overview
  46. 8.8.3 Unilife Corporation Inc Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Unilife Corporation Inc Parenteral Drugs Packaging Product Portfolio
  48. 8.8.5 Unilife Corporation Inc Recent Developments
  49. 8.9 West Pharmaceutical Services
  50. 8.9.1 West Pharmaceutical Services Company Information
  51. 8.9.2 West Pharmaceutical Services Business Overview
  52. 8.9.3 West Pharmaceutical Services Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 West Pharmaceutical Services Parenteral Drugs Packaging Product Portfolio
  54. 8.9.5 West Pharmaceutical Services Recent Developments
  55. 8.10 Terumo Corporation
  56. 8.10.1 Terumo Corporation Company Information
  57. 8.10.2 Terumo Corporation Business Overview
  58. 8.10.3 Terumo Corporation Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Terumo Corporation Parenteral Drugs Packaging Product Portfolio
  60. 8.10.5 Terumo Corporation Recent Developments
  61. 8.11 Berry Plastics Corporation
  62. 8.11.1 Berry Plastics Corporation Company Information
  63. 8.11.2 Berry Plastics Corporation Business Overview
  64. 8.11.3 Berry Plastics Corporation Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Berry Plastics Corporation Parenteral Drugs Packaging Product Portfolio
  66. 8.11.5 Berry Plastics Corporation Recent Developments
  67. 8.12 Owens-Illinois
  68. 8.12.1 Owens-Illinois Company Information
  69. 8.12.2 Owens-Illinois Business Overview
  70. 8.12.3 Owens-Illinois Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Owens-Illinois Parenteral Drugs Packaging Product Portfolio
  72. 8.12.5 Owens-Illinois Recent Developments
  73. 8.13 RPC Group
  74. 8.13.1 RPC Group Company Information
  75. 8.13.2 RPC Group Business Overview
  76. 8.13.3 RPC Group Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 RPC Group Parenteral Drugs Packaging Product Portfolio
  78. 8.13.5 RPC Group Recent Developments
  79. 8.14 Graphic Packaging Group
  80. 8.14.1 Graphic Packaging Group Company Information
  81. 8.14.2 Graphic Packaging Group Business Overview
  82. 8.14.3 Graphic Packaging Group Parenteral Drugs Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Graphic Packaging Group Parenteral Drugs Packaging Product Portfolio
  84. 8.14.5 Graphic Packaging Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Parenteral Drugs Packaging Value Chain Analysis
  2. 9.1.1 Parenteral Drugs Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Parenteral Drugs Packaging Production Mode & Process
  6. 9.2 Parenteral Drugs Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Parenteral Drugs Packaging Distributors
  9. 9.2.3 Parenteral Drugs Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst